首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human APP Abeta Recombinant Antibody(Aducanumab)

Anti-Human APP Abeta Recombinant Antibody(Aducanumab)

产品编号

YR1321

别名

科研级 Aducanumab ( 阿度努单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Aducanumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Aducanumab ( 阿度努单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Aducanumab
Catalog NumberYR1321
Molecular NameAducanumab
CAS Number1384260-65-4
TargetAPP Abeta[Homo sapiens]
Antibody IsotypeIgG1 Kappa
ClonityMonoclonal
Size1mg, 5mg
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundAducanumab, sold under the brand name Aduhelm, is a medication used to treat Alzheimer's disease (AD). It is an amyloid beta-directed monoclonal antibody. Aducanumab targets aggregated forms of Amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价